Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
334 | 3 | HYPERTENSION//ARTERIAL STIFFNESS//AMBULATORY BLOOD PRESSURE MONITORING | 37828 |
1592 | 2 | MEDICATION ADHERENCE//ADHERENCE//HYPERTENSION | 7424 |
23431 | 1 | REVISIT INTERVAL//MRC TRIAL//ABSOLUTE BENEFIT OF TREATMENT | 369 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | REVISIT INTERVAL | authKW | 341643 | 1% | 100% | 4 |
2 | MRC TRIAL | authKW | 192173 | 1% | 75% | 3 |
3 | ABSOLUTE BENEFIT OF TREATMENT | authKW | 85411 | 0% | 100% | 1 |
4 | ADVERSE EXPERIENCE REPORTING | authKW | 85411 | 0% | 100% | 1 |
5 | ANGIOTENSIN CONVERTING ENZYME INHIBITORS ANGIOTENSIN II SUBTYPE 1 RECEPTOR ANTAGONIST | authKW | 85411 | 0% | 100% | 1 |
6 | ANTIHYPERTENSIVE DRUG USAGE | authKW | 85411 | 0% | 100% | 1 |
7 | ANTIHYYPERTENSIVE THERAPY | authKW | 85411 | 0% | 100% | 1 |
8 | AUDIT PROTOCOL | authKW | 85411 | 0% | 100% | 1 |
9 | BBB STUDY | authKW | 85411 | 0% | 100% | 1 |
10 | BLOOD PRESSURE REDUCTION TRENDS | authKW | 85411 | 0% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 2801 | 26% | 0% | 95 |
2 | Medicine, General & Internal | 2093 | 35% | 0% | 129 |
3 | Health Care Sciences & Services | 1167 | 12% | 0% | 46 |
4 | Primary Health Care | 957 | 5% | 0% | 19 |
5 | Health Policy & Services | 574 | 7% | 0% | 25 |
6 | Cardiac & Cardiovascular System | 267 | 12% | 0% | 43 |
7 | Pharmacology & Pharmacy | 138 | 14% | 0% | 50 |
8 | Public, Environmental & Occupational Health | 138 | 9% | 0% | 34 |
9 | Medical Informatics | 126 | 2% | 0% | 9 |
10 | Geriatrics & Gerontology | 14 | 1% | 0% | 5 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CATALONIA PROGRAMME | 85411 | 0% | 100% | 1 |
2 | CITI2 | 85411 | 0% | 100% | 1 |
3 | CLIN 284 CARNEGIE 600 N WOLFE ST | 85411 | 0% | 100% | 1 |
4 | EPIDEMIOL SOCIAL MED CLIN EPIDEMIOL UNIT | 85411 | 0% | 100% | 1 |
5 | HADASSAH EIN KAREM | 85411 | 0% | 100% | 1 |
6 | HYPERTENS SECT 111DJC | 85411 | 0% | 100% | 1 |
7 | PORTSMOUTH SE HANTS HLTH AUTHOR | 85411 | 0% | 100% | 1 |
8 | SERV CLIN MANAGEMENT | 85411 | 0% | 100% | 1 |
9 | SOCIOECON POLICY DEV | 85411 | 0% | 100% | 1 |
10 | ABORAT PREVENT TREATMENT CARDIOVASC DIS | 42704 | 0% | 50% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF HUMAN HYPERTENSION | 23384 | 9% | 1% | 32 |
2 | NEW ZEALAND MEDICAL JOURNAL | 17412 | 7% | 1% | 27 |
3 | JOURNAL OF HYPERTENSION | 5439 | 7% | 0% | 25 |
4 | AMERICAN JOURNAL OF HYPERTENSION | 3615 | 4% | 0% | 16 |
5 | CLINICAL AND EXPERIMENTAL HYPERTENSION | 3319 | 2% | 0% | 9 |
6 | ZEITSCHRIFT FUR LYMPHOLOGIE-JOURNAL OF LYMPHOLOGY | 1984 | 0% | 2% | 1 |
7 | PHARMACOECONOMICS | 1848 | 2% | 0% | 7 |
8 | DRUG INFORMATION JOURNAL | 1234 | 1% | 0% | 4 |
9 | JOURNAL OF INTERNAL MEDICINE | 1091 | 2% | 0% | 7 |
10 | MEDICAL CARE | 1018 | 2% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |